ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "health behaviors"

  • Abstract Number: 1832 • ACR Convergence 2020

    Barriers to Medication Adherence and Degree of Nonadherence in a Systemic Lupus Erythematosus Outpatient Population

    Courtney Hardy1, Dafna Gladman2, Jiandong Su3, Nathalie Rozenbojm4 and Murray Urowitz5, 1University of Toronto, Toronto, ON, Canada, 2Krembil Research Institute, Toronto Western Hospital, Toronto, ON, Canada, 3University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, ON, Canada, 4University Health Network, Toronto, ON, Canada, 5University Health Network, University of Toronto, Toronto, ON, Canada

    Background/Purpose: It has been reported that 50% to 75% of patients with SLE do not adhere to their medications. However, the reasons for nonadherence are not clear.…
  • Abstract Number: 0468 • ACR Convergence 2020

    Concerns and Health-Related Behaviors During the COVID-19 Pandemic in Patients with or Without Autoimmune Rheumatic Disease in a Large Physician Network

    Michael George1, Shilpa Venkatachalam2, Shubhasree Banerjee1, Joshua Baker1, Peter Merkel1, David Curtis3, Kelly Gavigan4, Maria (Maio) Danila5, Daniel Kirby6, George Munoz7, William Sunshine8, William Nowell9 and Jeffrey R Curtis10, 1University of Pennsylvania, Philadelphia, PA, 2Global Healthy Living Foundation, Upper Nyack, 3Global Healthy Living Foundation, New York City, 4Global Healthy Living Foundation, Upper Nyack, NY, 5University of Alabama at Birmingham (UAB), Birmingham, AL, 6AARA, Charlotte, NC, 7AARA, Aventura, FL, 8AARA, Boca Raton, FL, 9Global Healthy Living Foundation, New York City, NY, 10Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Patients with autoimmune rheumatic diseases (ARD) may be particularly concerned about COVID-19. We aimed to compare concerns and health-related behaviors of patients with common…
  • Abstract Number: 1980 • ACR Convergence 2020

    Understanding the Relationship Between Illness Perceptions and Self-Efficacy Among Latin Americans with SLE Through the Hablemos De Lupus Facebook Page

    Erica Crosley1, Claudia Elera-Fitzcarrald2, Leandro Gabriel Ferreyra Garrot3, Yurilis Fuentes-Silva4, Soledad Ibañez5, Bernardo Pons-Estel6, Cristina Reátegui-Sokolova7 and Cristina Drenkard8, 1The Johns Hopkins University School of Medicine, Baltimore, MD, 2Department of Rheumatology. Hospital Nacional Guillermo Almenara Irigoyen. EsSalud; Universidad Científica del Sur, Lima, Peru, 3Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 4Universidad de Oriente, Ciudad Bolívar, Venezuela, 5Sanatorio Güemes, Buenos Aires, Argentina, 6Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Santa Fe, Argentina, 7Hospital Guillermo Almenara Irigoyen; Universidad San Ignacio de Loyola, Lima, Peru, 8Division of Rheumatology, Department of Medicine, Emory School of Medicine, Atlanta, GA

    Background/Purpose: SLE disproportionately strikes Latinos, who are also at high risk for poor outcomes. Self-efficacy (SE) to manage chronic disease correlates with outcomes through self-management…
  • Abstract Number: 0585 • ACR Convergence 2020

    Cost-effectiveness of Motivational Counselling and SMS-reminders on Daily Sitting Time in Patients with Rheumatoid Arthritis

    Jan Sorensen1, Mette Aadahl2, Merete Hetland3, Bente Appel Esbensen4 and Tanja Thomsen2, 1Healthcare Outcomes Research Centre, Dublin, Dublin, Ireland, 2Centre for Clinical Research and Prevention, Frederiksberg, Denmark, 3Copenhagen Center for Arthritis Research (COPECARE), Glostrup, Denmark, 4University of Copenhagen, Glostrup, Hovedstaden, Denmark

    Background/Purpose: The “Joint Resources – Sedentary Behaviour” randomised controlled trial (RCT) (1,2,3) aimed to reduce sedentary behaviour in patients with rheumatoid arthritis (RA) by means…
  • Abstract Number: 0591 • ACR Convergence 2020

    Intervention to Improve SLE Medication Adherence Using Surescripts Pharmacy Refill Data

    Kai Sun1, Jennifer Rogers2, Rebecca Sadun3, Amanda Eudy3, Jayanth Doss3, Lisa Criscione-Schreiber4, Ann Cameron Barr5, Lena Eder6, Mithu Maheswaranathan3, Amy Corneli7, Hayden Bosworth1 and Megan Clowse8, 1Duke University Hospital, Durham, 2Duke University Hospital, Durham, DE, 3Duke University, Durham, NC, 4Division of Rheumatology and Clinical Immunology, Department of Medicine, Duke University Medical Center, Durham, NC, 5Duke University Hospital, Durham, NC, 6Duke University Hospital, Chapel Hill, NC, 7Duke University, Durham, 8Duke University, Chapel Hill, NC

    Background/Purpose: Medication nonadherence is as high as 80% among SLE patients and leads to higher morbidity, mortality, and healthcare costs. Few studies have tested interventions…
  • Abstract Number: 0799 • ACR Convergence 2020

    Effectiveness of Electronic Drug Monitoring Feedback in Order to Increase Adherence in RA Patients Starting with a Biological DMARD

    Renske Hebing1, Wouter Bos1, Mike Nurmohamed2 and Bart van den Bemt3, 1Amsterdam Rheumatology and Immunology Center | Reade, Amsterdam, Netherlands, 2Amsterdam Rheumatology and immunology Center, location Reade and Amsterdam UMC, VU medical center, Amsterdam, Netherlands, 3Sint Maartenskliniek, Nijmegen, Netherlands

    Background/Purpose: Medication non-adherence in rheumatoid arthritis (RA) is associated with disease flares, increased disability and increased costs. Electronic Monitoring Feedback (EMF) to improve adherence has…
  • Abstract Number: 125 • 2020 Pediatric Rheumatology Symposium

    Feasibility and Pilot Study of Mental Health Screening in Juvenile Myositis

    Kaveh Ardalan1, Alison Manning 1, Brian Feldman 2, Gary Maslow 1 and Andrea Knight 3, 1Duke University Medical Center, Durham, 2The Hospital for Sick Children, Toronto, Canada, 3SickKids Research Institute, Toronto, Canada

    Background/Purpose: Juvenile myositis (JM) negatively affects health-related quality of life due to chronic weakness, skin/muscle damage, multiorgan dysfunction, and side effects of immunosuppression. While JM’s…
  • Abstract Number: 1428 • 2018 ACR/ARHP Annual Meeting

    Parental Involvement and Adolescents/Young Adults Self-Management during the Transition Period: A Cross-Sectional Survey in Childhood Onset Rheumatic Diseases

    Pauline Yi1, Hana Conlon2, Jae Hee Yun3, Kayla Neville2, George Danias2, Anca Askanase4 and Lisa F. Imundo5, 1Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, 2Rheumatology, Columbia University Medical Center, New York, NY, 3Medicine/Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, 4Columbia University, College of Physicians & Surgeons, New York, NY, 5Pediatrics, Columbia University Medical Center, New York, NY

    Background/Purpose: A NIH focus group study found that adolescents and young adults (AYA) with active disease relied heavily on their parents for disease management. It…
  • Abstract Number: 1706 • 2018 ACR/ARHP Annual Meeting

    Development of an Online Lupus Self-Management Program Based on the Transtheoretical Model of Change

    Sarah Gilman1, Deborah Levesque2, Carol Cummins2, Daniel J. Wallace3, Victoria P. Werth4,5, Rosalind Ramsey-Goldman6, Margaret Kaniewski7 and Patricia Davidson8, 1Wayfinder Health Strategies, Falls Church, VA, 2ProChange Behavior Systems Inc., West Kingston, RI, 3Division of Rheumatology, Cedars Sinai Medical Center, Los Angeles, CA, 4Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, 5University of Pennsylvania, Philadelphia, PA, 6FSM, Northwestern University, Chicago, IL, 7Centers for Disease Control & Prevention, Atlanta, GA, 8Lupus Foundation of America, Washington, DC

    Background/Purpose: The Lupus Foundation of America is in Year 3 of a 5-year cooperative agreement with the Centers for Disease Control and Prevention to develop…
  • Abstract Number: 1241 • 2016 ACR/ARHP Annual Meeting

    Understanding Lupus Patients’ Ability to Work with Numbers

    Alexa Meara1, Mary-Kate Tompkins2, Kimberly Fisher2, Holly Steigelman2, Wael N. Jarjour3, Stacy P. Ardoin4 and Ellen Peters5, 1Internal Medicine/Rheumatology, The Ohio State University, Columbus, OH, 2The Ohio State University, Columbus, OH, 3Department of Rheumatology/Medicine, Ohio State University, Columbus, OH, 4Pediatric & Adult Rheumatology, Ohio State University, Columbus, OH, 5Ohio State University, Columbus, OH

    Background/Purpose: Systemic lupus erythematous (SLE) is a heterogeneous disease with high morbidity and mortality affecting approximately 20-150 cases per 100,000 people. The risk of early…
  • Abstract Number: 25 • 2015 ACR/ARHP Annual Meeting

    Attrition and Participant Characteristics in a Rheumatoid Arthritis Cohort

    Angela Cesta1, Xiuying Li1, Mark Tatangelo2,3 and Claire Bombardier1,4,5, 1Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada, 2Clinical Decision Making and Health Care, Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada, 3University of Toronto, Toronto, ON, Canada, 4Division of Rheumatology and Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada, 5Division of Rheumatology, Mount Sinai Hospital, Toronto, ON, Canada

    Background/Purpose: The generalizability and validity of in longitudinal observational studies is contingent on participant characteristics. If attrition is not random, it is important to identify…
  • Abstract Number: 452 • 2015 ACR/ARHP Annual Meeting

    Associations Between Arthritis Patient, Disease-Specific and Provider Characteristics and Medication Information Source Use

    Lorie Geryk1, Susan J. Blalock2, Robert DeVellis3, Joanne M. Jordan3 and Delesha Carpenter4, 1Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, 2Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 3Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, 4Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Asheville, NC

    Background/Purpose: Few studies have described how patient, disease-specific, and provider factors are associated with medication information source use among arthritis patients. We address this research…
  • Abstract Number: 2382 • 2015 ACR/ARHP Annual Meeting

    An Outsourced Health-Enhancing Physical Activity Program for People with Rheumatoid Arthritis. Exploration of the Maintenance Phase

    Christina H. Opava1, Birgitta Nordgren1, Cecilia Fridén1, Ingrid Demmelmaier1, Gunnar Bergström2, Ingrid E. Lundberg3, Alyssa B. Dufour1,4, Thomas Nessen1 and PARA Study Group, 1Department of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, Huddinge, Sweden, 2Institute of Environmental Medicine, Unit of Intervention and Implementation Research, Karolinska Institutet, Stockholm, Sweden, 3Karolinska University Hospital, Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, 4Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School & Beth Israel Deaconess Medical Center, Boston, MA

    Background/Purpose: Health-enhancing physical activity (HEPA), i.e. at least 150 weekly minutes of moderate-intensity and at least twice-weekly muscle-strengthening activities, is recommended for every adult. Long-term studies on HEPA…
  • Abstract Number: 113 • 2013 ACR/ARHP Annual Meeting

    Posttraumatic Stress Disorder and Risk For Incident Rheumatoid Arthritis

    Yvonne C. Lee1, Susan Malspeis2, Jessica Agnew-Blais3, Katherine Keyes4, Laura Kubzansky3, Andrea Roberts3, Karestan Koenen4 and Elizabeth Karlson5, 1Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 2Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 3Harvard School of Public Health, Boston, MA, 4Columbia University Mailman School of Public Health, New York, NY, 5Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Woman's Hospital, Boston, MA

    Background/Purpose: Posttraumatic stress disorder (PTSD) is associated with autoimmune dysfunction, but the relationship between PTSD and the incidence of autoimmune disorders has not been studied…
  • Abstract Number: 2430 • 2012 ACR/ARHP Annual Meeting

    Using the Internet in Help-Seeking As Illness Develops in Early Rheumatoid Arthritis

    Anne F. Townsend1, Jenny Leese1, Catherine L. Backman2, Paul M. Adam3 and Linda C. Li4, 1Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, 2Occupational Science & Occupational Therapy, The University of British Columbia, Vancouver, BC, Canada, 3Rheumatology Liaison, Mary Pack Arthritis Centre, Vancouver, BC, Canada, 4Physical Therapy, Arthritis Centre of Canada, Richmond, BC, Canada

    Background/Purpose: Patients’ Internet use for health purposes is regarded as potentially transformational. Using on-line resources is associated with the emergence of the e-patient; broadly defined…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology